Several recent studies have suggested HRT is a risk factor in various conditions, notably Alzheimer's - now UK boffins have ...

Professor Markus Sauer from the Biocentre of Julius-Maximilians-Universität (JMU) Würzburg in Bavaria, Germany ...

GLP-1 drugs, widely used for treating metabolic disorders, often face issues with long term tolerability, leading to side effects such as sarcopenia and bone density loss. These complications ...

Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...

New treatments like dotinurad provide safer, more effective solutions for millions battling gout and hyperuricemia.

A breakthrough in prostate cancer treatment has seen a drug shrink tumours in advanced disease ...

The drug, known as NXP800, works by targeting the heat shock factor 1 (HSF1) pathway, a cellular protective mechanism that is ...

Cullinan offers promising oncology and autoimmune products, strong financials, and potential for growth, making it a ...

The FDA has granted BTD to GSK’22, a B7-H3-targeted antibody-drug conjugate, for the treatment of adult patients with ...

Denali Therapeutics Inc.'s stock remains stable despite trial setback in ALS. BLA filing for MPS II treatment on track. Click ...